Literature DB >> 6824784

Monoclonal antibody studies in non-Hodgkin's lymphoma.

A C Aisenberg, B M Wilkes, N L Harris.   

Abstract

The cell lineage of suspensions prepared from 85 non-Hodgkin's lymphomas was investigated with a panel of 10 monoclonal antibodies and conventional surface marker techniques. Surface immunoglobulin, assessed with specific heteroantisera, proved to be the most useful characteristic and defined the clonal character and B-cell lineage of 63 specimens: almost all nodular lymphocytic (21 of 22) and diffuse lymphocytic (11 of 13) lymphomas, most diffuse histiocytic (29 of 33) and diffuse mixed (2 of 2) lymphomas, and a few nodular mixed (2 of 12) and nodular histiocytic (0 of 3) lymphomas. Monoclonal antibodies provided useful ancillary surface marker criteria. Thus, positivity with OKT1 (which detects both thymic and peripheral T cells) in the absence of reactivity with monoclonal antisera, which detect only peripheral T cells (OKT3, OKT4, OKT8, and OKT11), was seen only in diffuse lymphocytic lymphoma of B lineage. Ia-like antigen could be demonstrated in all B-cell lymphocytic lymphomas and most B-cell diffuse histiocytic lymphomas. Approximately one-half of diffuse histiocytic lymphomas also reacted with OKT9, which detects the transferrin receptor, while few lymph nodes involved by other conditions displayed this reactivity. Most diffuse histiocytic lymphomas and many non-Hodgkin's lymphomas of other subtypes reacted with OKT10, an antiserum that detects an antigen on replicating lymphoid cells. The lineage of approximately one-fourth of the lymphoma suspensions was not resolved conclusively: In most of these, T lymphocytes predominated with a normal proportion of inducer-helper (OKT4) and cytotoxic-suppressor (OKT8) cells. The inability to establish the clonal character of T-cell proliferation in cell suspensions remains an obstacle to completely defining the lineage of non-Hodgkin's lymphomas.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824784

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Expression of T3 and T11 determinants on human peripheral lymphocytes as analysed by the indirect antiglobulin rosetting reaction (IARR) and indirect immunofluorescence.

Authors:  D G Haegert
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

Review 2.  Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma.

Authors:  L J Picker; L M Weiss; L J Medeiros; G S Wood; R A Warnke
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

3.  A monoclonal antibody to the heavy chain of human IgM with a particular reaction pattern in human B-cell malignancies.

Authors:  M Henke; S Santos; C D Winberg; J E Shively
Journal:  Blut       Date:  1987-09

4.  Diagnostic immunopathology.

Authors:  P A Cancilla; A J Cochran; F Naeim; J W Said
Journal:  West J Med       Date:  1986-07

5.  Modified immunocytochemical slide technique for demonstrating surface antigens on viable cells.

Authors:  N Frickhofen; K J Bross; W Heit; H Heimpel
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

6.  "Well-differentiated" lymphocytic neoplasms. Immunologic findings correlated with clinical presentation and morphologic features.

Authors:  L J Medeiros; J G Strickler; L J Picker; A B Gelb; L M Weiss; R A Warnke
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

7.  Primary malignant lymphoma of the brain: an immunohistochemical study of eight cases using a panel of monoclonal and heterologous antibodies.

Authors:  T Kumanishi; K Washiyama; T Saito; A Nishiyama; S Abe; T Tanaka
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Peripheral T-cell lymphomas. Immunophenotype, lymphokine production, and immunologic functional characteristics of the lymph-node malignant T cells.

Authors:  S Raziuddin; T Malatani; S al-Sedairy; A H al-Saigh
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

9.  Distribution of T-cell subsets in follicular and diffuse lymphomas of B-cell type.

Authors:  N L Harris; A K Bhan
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

10.  Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.

Authors:  T Stokke; H Holte; L Smedshammer; E B Smeland; O Kaalhus; H B Steen
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.